Group 1 - The company reported a total revenue of 1.494 billion, representing a year-on-year growth of 12.9% for the first half of 2025 [1] - The net profit turned positive, reaching 12.5 million, while the adjusted net profit hit a new high of 17.6 million, up 16.8% year-on-year [1] - Online retail pharmacy service revenue significantly increased to 864 million, a growth of 28.2% year-on-year, while comprehensive medical service revenue reached 357 million, growing by 11.4% [1] Group 2 - As of June 30, 2025, the platform had 52.8 million registered users, reflecting a steady growth of 15.8% year-on-year, and the number of registered doctors increased to 229,000 [1] - Monthly active users surged by 34.4% year-on-year to 11.9 million, with a high user retention rate, as the repurchase rate for paying users rose to 85.4% [1] - The company expanded its drug SKU to 216,000, with approximately 62% being prescription drugs, and established partnerships with over 1,650 suppliers and 980 pharmaceutical companies [2] Group 3 - The company integrated advanced AI capabilities into its services, completing the "AI+H2H" technology upgrade, which enhances user service, supply chain, and content production [2] - The integration of innovative tools with internet healthcare scenarios allows for precise and efficient responses to both immediate health consultations and long-term health management needs [2]
方舟健客(06086.HK)发布2025年中期业绩，经调整净利润再创新高，完成“AI+H2H”技术升级